FENNEC PHARMACEUTICALS INC. Capital Expenditures
FENNEC PHARMACEUTICALS INC. (FENC) reported Capital Expenditures of $0 for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2014-11-13
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2014-09-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2014-06-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2014-03-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for the quarter ending 2013-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2013 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2012 was $0.00.
- FENNEC PHARMACEUTICALS INC. payments to acquire property, plant, and equipment for fiscal 2011 was $0.00.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 178 month | Payments to Acquire Property, Plant, and Equipment 181 month | Payments to Acquire Property, Plant, and Equipment 184 month | Payments to Acquire Property, Plant, and Equipment 187 month | Payments to Acquire Property, Plant, and Equipment 190 month | Payments to Acquire Property, Plant, and Equipment 193 month | Payments to Acquire Property, Plant, and Equipment 196 month | Payments to Acquire Property, Plant, and Equipment 199 month | Payments to Acquire Property, Plant, and Equipment 202 month | Payments to Acquire Property, Plant, and Equipment 205 month | Payments to Acquire Property, Plant, and Equipment 208 month | Payments to Acquire Property, Plant, and Equipment 211 month | Payments to Acquire Property, Plant, and Equipment 214 month | Payments to Acquire Property, Plant, and Equipment 217 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $1.44M 10-Q · filed 2014-11-13 | |||||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $1.44M 10-Q · filed 2014-08-11 | |||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $1.44M 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 derived: sum of 3 quarters · filed 2014-11-13 | $0.00 10-K · filed 2014-03-31 | $1.44M 10-K · filed 2014-03-31 | |||||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-11-13 | $1.44M 10-Q · filed 2013-11-18 | |||||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-08-11 | $1.44M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $1.44M 10-Q · filed 2013-05-13 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $1.44M 10-K · filed 2013-04-01 | |||||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-18 | $0.00 derived: sum of 2 quarters · filed 2013-11-18 | $0.00 10-Q · filed 2013-11-18 | $0.00 derived: sum of 4 quarters · filed 2013-11-18 | $1.44M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $0.00 derived: sum of 4 quarters · filed 2013-08-09 | $1.44M 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-13 | $0.00 derived: sum of 2 quarters · filed 2013-05-13 | $0.00 derived: sum of 3 quarters · filed 2013-05-13 | $0.00 derived: sum of 4 quarters · filed 2013-05-13 | $1.44M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $0.00 derived: sum of 2 quarters · filed 2013-04-01 | $0.00 derived: sum of 3 quarters · filed 2013-04-01 | $0.00 10-K · filed 2013-04-01 | $1.44M 10-K · filed 2012-03-27 | |||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $1.44M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-13 | $0.00 10-Q · filed 2012-08-13 | $1.44M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |